Deucravacitinib

Deucravacitinib is a targeted treatment for patients with moderate-to-severe plaque psoriasis who qualify for systemic therapy or phototherapy

Anant Labs manufacture and furnish high quality Deucravacitinib impurities for global markets. Our Deucravacitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.